Abstract
Introduction Ultrasound-guided high ankle block can provide prolonged analgesia for foot and ankle surgeries while preserving ankle motor function. Given that fragile elderly patients are prone to cognitive impairment after general anesthesia, this study intends to implement high ankle block for fragile elderly patients undergoing foot and ankle fracture surgery, and use intraoperative electroencephalogram (EEG) analysis combined with postoperative scales to investigate its effect on patients’ postoperative cognitive function.
Methods and analysis This randomized controlled trial will be conducted in Xuzhou Central Hospital. A total of 126 elderly patients scheduled to undergo unilateral ankle fracture (uni/bi-/triple ankle) incision and reduction internal fixation (ORIF) surgery will be randomly assigned to either the HAB group or the GB group in a 1:1 ratio. Patients will receive ultrasound-guided high ankle block and general anesthesia (HAB group) or general anesthesia alone (GB group). Multimodal analgesia will include intraoperative flurbiprofen ester and postoperative patients will be given appropriate medications according to the postoperative pain management “three-step ladder”. The primary outcome indicator was the incidence of dNCR at 7th day postoperation. The secondary outcome indicators were the incidence of dNCR at 1st and 30th days postoperation; alpha relative power, alpha power, and burst inhibition ratio in each brain region at 30 min after induction of anesthesia; MoCA scores, patient stress response indexes: ACTH, NE, Ang-II, β-EP, Glu, and Cor levels; patients’ VAS pain scores; patients’ satisfaction scores; first time getting out of bed postoperatively; and time of discharge from the hospital. Safety outcomes were dizziness, headache, vomiting, urinary retention, bradycardia, tachycardia, hypotension, and hypertension.
Ethics and dissemination Ethics approval was obtained from the Ethics Committee of the Xuzhou Central Hospital. All patients will provide written informed consent. The results of this study will be published in a peer-reviewed journal.
Trial registration number Chinese Clinical Trial Registry (ChiCTR2400050927)
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ChiCTR2400050927
Funding Statement
Funding: This work was supported by National Natural Science Foundation of China，81700078；Xuzhou Science and Technology Plan Project，KC21055；Xuzhou Medical Key Talent Project，XWRCHT20220051.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
